Detail
Článek
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

In Vitro Assessment of the Genotoxic Potential of Pristine Graphene Platelets

A. Malkova, T. Svadlakova, A. Singh, M. Kolackova, R. Vankova, P. Borsky, D. Holmannova, A. Karas, L. Borska, Z. Fiala

. 2021 ; 11 (9) : . [pub] 20210827

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc21024069

Grantová podpora
CZ.02.1.01/0.0/0.0/17_048/0007421 Ministerstvo Školství, Mládeže a Tělovýchovy
PROGRES Q40/09 Charles University, Faculty of Medicine in Hradec Kralove
PROGRES Q40/10 Charles University, Faculty of Medicine in Hradec Kralove
SVV-260397/2017 Charles University, Faculty of Medicine in Hradec Kralove

(1) Background: Graphene is a two-dimensional atomic structure with a wide range of uses, including for biomedical applications. However, knowledge of its hazards is still limited. This work brings new cytotoxic, cytostatic, genotoxic and immunotoxic data concerning the in vitro exposure of human cell line to two types of graphene platelets (GP). It also contributes to the formation of general conclusions about the health risks of GP exposure. (2) Methods: In vitro exposure of a THP-1 cell line to three concentrations of two GP over 40 h. The cytotoxic potential was assessed by the measurement of LDH and glutathione (ROS) and by a trypan blue exclusion assay (TBEA); the cytostatic and genotoxic potential were assessed by the cytokinesis-block micronucleus (CBMN) test; and the immunotoxic potential was assessed by the measurement of IL-6, IL-10 and TNF-α. (3) Results: We found a significant dose-dependent increase in DNA damage (CBMN). The lowest observed genotoxic effect levels (LOGEL) were 5 µg/mL (GP1) and 30 µg/mL (GP2). We found no significant leaking of LDH from cells, increase in dead cells (TBEA), induction of ROS, increased levels of cytostasis, or changes in IL-6, IL-10 and TNF-α levels. (4) Conclusions: The genotoxicity increased during the short-term in vitro exposure of THP-1 to two GP. No increase in cytotoxicity, immunotoxicity, or cytostasis was observed.

000      
00000naa a2200000 a 4500
001      
bmc21024069
003      
CZ-PrNML
005      
20211013134050.0
007      
ta
008      
211006s2021 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/nano11092210 $2 doi
035    __
$a (PubMed)34578525
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Malkova, Andrea $u Institute of Preventive Medicine, Faculty of Medicine in Hradec Kralove, Charles University, 50003 Hradec Kralove, Czech Republic $u Institute of Pathological Physiology, Faculty of Medicine in Hradec Kralove, Charles University, 50003 Hradec Kralove, Czech Republic
245    10
$a In Vitro Assessment of the Genotoxic Potential of Pristine Graphene Platelets / $c A. Malkova, T. Svadlakova, A. Singh, M. Kolackova, R. Vankova, P. Borsky, D. Holmannova, A. Karas, L. Borska, Z. Fiala
520    9_
$a (1) Background: Graphene is a two-dimensional atomic structure with a wide range of uses, including for biomedical applications. However, knowledge of its hazards is still limited. This work brings new cytotoxic, cytostatic, genotoxic and immunotoxic data concerning the in vitro exposure of human cell line to two types of graphene platelets (GP). It also contributes to the formation of general conclusions about the health risks of GP exposure. (2) Methods: In vitro exposure of a THP-1 cell line to three concentrations of two GP over 40 h. The cytotoxic potential was assessed by the measurement of LDH and glutathione (ROS) and by a trypan blue exclusion assay (TBEA); the cytostatic and genotoxic potential were assessed by the cytokinesis-block micronucleus (CBMN) test; and the immunotoxic potential was assessed by the measurement of IL-6, IL-10 and TNF-α. (3) Results: We found a significant dose-dependent increase in DNA damage (CBMN). The lowest observed genotoxic effect levels (LOGEL) were 5 µg/mL (GP1) and 30 µg/mL (GP2). We found no significant leaking of LDH from cells, increase in dead cells (TBEA), induction of ROS, increased levels of cytostasis, or changes in IL-6, IL-10 and TNF-α levels. (4) Conclusions: The genotoxicity increased during the short-term in vitro exposure of THP-1 to two GP. No increase in cytotoxicity, immunotoxicity, or cytostasis was observed.
655    _2
$a časopisecké články $7 D016428
700    1_
$a Svadlakova, Tereza $u Institute of Preventive Medicine, Faculty of Medicine in Hradec Kralove, Charles University, 50003 Hradec Kralove, Czech Republic $u Institute of Clinical Immunology and Allergology, University Hospital Hradec Kralove and Faculty of Medicine in Hradec Kralove, Charles University, 50005 Hradec Kralove, Czech Republic
700    1_
$a Singh, Avni $u Institute of Clinical Immunology and Allergology, University Hospital Hradec Kralove and Faculty of Medicine in Hradec Kralove, Charles University, 50005 Hradec Kralove, Czech Republic
700    1_
$a Kolackova, Martina $u Institute of Clinical Immunology and Allergology, University Hospital Hradec Kralove and Faculty of Medicine in Hradec Kralove, Charles University, 50005 Hradec Kralove, Czech Republic
700    1_
$a Vankova, Radka $u Institute of Clinical Immunology and Allergology, University Hospital Hradec Kralove and Faculty of Medicine in Hradec Kralove, Charles University, 50005 Hradec Kralove, Czech Republic
700    1_
$a Borsky, Pavel $u Institute of Preventive Medicine, Faculty of Medicine in Hradec Kralove, Charles University, 50003 Hradec Kralove, Czech Republic $u Institute of Pathological Physiology, Faculty of Medicine in Hradec Kralove, Charles University, 50003 Hradec Kralove, Czech Republic
700    1_
$a Holmannova, Drahomira $u Institute of Preventive Medicine, Faculty of Medicine in Hradec Kralove, Charles University, 50003 Hradec Kralove, Czech Republic
700    1_
$a Karas, Adam $u Institute of Preventive Medicine, Faculty of Medicine in Hradec Kralove, Charles University, 50003 Hradec Kralove, Czech Republic
700    1_
$a Borska, Lenka $u Institute of Preventive Medicine, Faculty of Medicine in Hradec Kralove, Charles University, 50003 Hradec Kralove, Czech Republic
700    1_
$a Fiala, Zdenek $u Institute of Preventive Medicine, Faculty of Medicine in Hradec Kralove, Charles University, 50003 Hradec Kralove, Czech Republic
773    0_
$w MED00193495 $t Nanomaterials (Basel, Switzerland) $x 2079-4991 $g Roč. 11, č. 9 (2021)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34578525 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20211006 $b ABA008
991    __
$a 20211013134047 $b ABA008
999    __
$a ind $b bmc $g 1708182 $s 1144566
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 11 $c 9 $e 20210827 $i 2079-4991 $m Nanomaterials $n Nanomaterials (Basel) $x MED00193495
GRA    __
$a CZ.02.1.01/0.0/0.0/17_048/0007421 $p Ministerstvo Školství, Mládeže a Tělovýchovy
GRA    __
$a PROGRES Q40/09 $p Charles University, Faculty of Medicine in Hradec Kralove
GRA    __
$a PROGRES Q40/10 $p Charles University, Faculty of Medicine in Hradec Kralove
GRA    __
$a SVV-260397/2017 $p Charles University, Faculty of Medicine in Hradec Kralove
LZP    __
$a Pubmed-20211006

Najít záznam

Citační ukazatele

Nahrávání dat...

Možnosti archivace

Nahrávání dat...